ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Top Brokers

More Brokers

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
AI Sign In Premium IconPremium Help Menu
FTSE 100
8,732.46
-0.37%
Dow Jones
44,546.08
-0.37%
Gold vs US Dollar
2,882.735
0.00%
Brent Oil
74.39
0.00%
Bitcoin
97,066.14
-0.54%
Pepperstone
Advertisement
Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. Galapagos NV (GLPG)

  7. Galapagos NV (GLPG) News

Galapagos NV (GLPG)

Galapagos NV
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:GLPG
DateTimeSourceHeadlineSymbolCompany
12/02/202522:06Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:GLPGGalapagos NV
12/02/202521:01GlobeNewswire Inc.Galapagos Reports Full Year 2024 Results and Provides Fourth Quarter Business UpdateNASDAQ:GLPGGalapagos NV
08/01/202513:00Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:GLPGGalapagos NV
08/01/202511:00Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:GLPGGalapagos NV
08/01/202506:30GlobeNewswire Inc.Galapagos to Unlock Shareholder Value by Declaring its Intent to Separate into Two Publicly Traded EntitiesNASDAQ:GLPGGalapagos NV
07/01/202521:01GlobeNewswire Inc.Galapagos to Present at the 43rd Annual J.P. Morgan Healthcare ConferenceNASDAQ:GLPGGalapagos NV
09/12/202412:37Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:GLPGGalapagos NV
07/12/202417:30GlobeNewswire Inc.Galapagos Announces Encouraging New Results from Ongoing Phase 1/2 Study of CD19 CAR T-Cell Therapy, GLPG5101, in Patients with Relapsed/Refractory Non-Hodgkin LymphomaNASDAQ:GLPGGalapagos NV
20/11/202421:32Edgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansNASDAQ:GLPGGalapagos NV
05/11/202421:01GlobeNewswire Inc.Galapagos to Present Results of Pioneering Innovation in Cancer Cell Therapy at ASH 2024NASDAQ:GLPGGalapagos NV
30/10/202420:01GlobeNewswire Inc.Galapagos Reports Third Quarter 2024 Financial Results and Provides Business UpdateNASDAQ:GLPGGalapagos NV
08/10/202420:35Edgar (US Regulatory)Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]NASDAQ:GLPGGalapagos NV
07/10/202410:03Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:GLPGGalapagos NV
07/10/202405:00GlobeNewswire Inc.Galapagos welcomes Oleg Nodelman to its Board of Directors to support strategic growthNASDAQ:GLPGGalapagos NV
30/09/202420:01GlobeNewswire Inc.Galapagos receives transparency notification from EcoR1 CapitalNASDAQ:GLPGGalapagos NV
16/09/202420:01GlobeNewswire Inc.Galapagos receives transparency notification from EcoR1 CapitalNASDAQ:GLPGGalapagos NV
03/09/202420:01GlobeNewswire Inc.Galapagos receives transparency notification from FMR LLCNASDAQ:GLPGGalapagos NV
23/08/202420:10Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:GLPGGalapagos NV
23/08/202420:01Edgar (US Regulatory)Form SC 13D - General Statement of Acquisition of Beneficial OwnershipNASDAQ:GLPGGalapagos NV
23/08/202405:00GlobeNewswire Inc.Galapagos announces FDA clearance of IND application for Phase 1/2 ATALANTA-1 study of CD19 CAR-T, GLPG5101, in relapsed/refractory non-Hodgkin lymphomaNASDAQ:GLPGGalapagos NV
21/08/202420:10Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:GLPGGalapagos NV
20/08/202420:01GlobeNewswire Inc.Galapagos receives transparency notification from FMR LLCNASDAQ:GLPGGalapagos NV
01/08/202420:01GlobeNewswire Inc.Galapagos reports half-year 2024 financial results and provides second quarter business updateNASDAQ:GLPGGalapagos NV
01/08/202420:01PR Newswire (US)BridGene Biosciences Expands Strategic Collaboration with Galapagos to Develop Selective Oral SMARCA2 PROTAC in Precision OncologyNASDAQ:GLPGGalapagos NV
14/06/202420:01GlobeNewswire Inc.Galapagos presents encouraging new data for CD19 CAR-T candidate GLPG5101 in non-Hodgkin lymphoma at EHA 2024NASDAQ:GLPGGalapagos NV
30/05/202420:44Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:GLPGGalapagos NV
30/05/202420:01GlobeNewswire Inc.Galapagos and Adaptimmune sign clinical collaboration agreement with an option to exclusively license Adaptimmune’s TCR T-cell therapy candidate, uza-cel, in head & neck cancer and potential future solid tumor indicationsNASDAQ:GLPGGalapagos NV
16/05/202420:28Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:GLPGGalapagos NV
16/05/202420:01GlobeNewswire Inc.Galapagos creates new subscription right plansNASDAQ:GLPGGalapagos NV
16/05/202412:11Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:GLPGGalapagos NV
 Showing the most relevant articles for your search:NASDAQ:GLPG

Your Recent History

USOTC
SCVUF
Siam Cement Uts (PK)
Delayed Upgrade Clock
    ADVFN Logo
    InvestorsHub

    United Kingdom
    Company
    Business
    Popular
    Get The App
    App Store
    Google Play

    Support: +44 (0) 203 8794 460 | support@advfn.com

    By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

    © 2025 ADVFN PLC - All Rights Reserved

    Go Ad-Free

    Subscribe to Ad free and enjoy an ad-free experience

    No Ads

    Try Now

    Keep the Ads